📈 The IPO Guide🔍 Analysing an Issue
Grey Market Premium — What It Really Tells You
GMP is an unofficial, unregulated, thinly traded quote that moves on sentiment. It is a useful sentiment reading and a poor forecast. Here is how to use it without being misled.
Grey market premium is the price at which IPO allotments are informally traded before listing, quoted as a premium over the issue price. A GMP of ₹120 on a ₹300 issue implies an expected listing around ₹420.
It is the most widely followed number in retail IPO investing and the least well understood.
What the grey market actually is
An unregulated, over-the-counter market operated by a small number of dealers, mostly by phone and messaging. There is no exchange, no order book, no clearing corporation, no settlement guarantee and no regulator.
Deals are private arrangements between individuals. They are not legally enforceable. If the counterparty does not pay, there is no recourse.
The quotes you see published on websites are collected from these dealers. They are not prices from a market you can access, verify or rely on.
Why it moves so much
The volumes behind a GMP quote are small relative to the issue. A handful of trades moves the number.
It responds to subscription data, to the anchor list, to how the broad market is trading, and to how other recent listings performed. None of those things changes the company’s business, but all of them change the quote — sometimes by half in a day.
The pattern that costs people money is a GMP that climbs through the bidding window, peaks around allotment, and fades in the two days before listing. By the time the stock actually opens, the premium that justified the application can be substantially gone.
The two application-level rates
Two other grey market terms are frequently confused with GMP, because they price something different.
Kostak rate. A fixed amount paid for an entire IPO application, before allotment is known. The seller receives it whether or not the application is allotted. The buyer takes the full risk of getting nothing.
Subject to sauda. The same trade, made conditional: the amount is paid only if the application is actually allotted. Because the buyer’s risk is lower, the quoted rate is higher.
Both are deals in applications, not in shares, and both are as unregulated as GMP itself.
Where GMP is genuinely useful
It is not worthless. Used carefully, it tells you something real:
- As a sentiment reading. A GMP near zero on an issue with strong subscription is a genuine tension worth noticing.
- As a relative measure. Comparing GMP across two issues in the same week says something about which one the market is more enthusiastic about.
- As a trend. The direction of the quote over the bidding window is more informative than its level on any single day.
What it is not is a forecast of the listing price, and it is least reliable in exactly the issues where it is highest.
Where it misleads
It says nothing about the business. GMP is a demand-supply signal for a listing pop. It carries no information about revenue quality, valuation or governance.
It does not affect your allotment. The draw does not consider it. A high GMP raises the number of applications, which lowers your odds.
It flatters small issues. A thin issue with a small free float can support a high premium on very little real money.
It can be gamed. In an unregulated market with published quotes and a small number of participants, an inflated quote to attract applications is not a hypothetical.
Two sanity checks
Compare the estimated listing price against valuation. If issue price plus GMP implies a P/E far above every listed peer, the grey market is pricing enthusiasm rather than value — and the correction usually arrives within weeks.
Watch the last two days. GMP between allotment and listing is the most informative reading, because sentiment has had time to settle and the anchor list and subscription data are fully known.
How to actually use it
Do your work on the business and the price first. Decide whether you want the shares at the issue price.
Then, if you like, glance at GMP as a rough gauge of what listing day might look like. It is the last input, not the first, and it should never be the reason you applied.
An issue you would not want at the issue price does not become a good investment because an unregulated quote says it might open higher.
Frequently asked questions
Is trading in the grey market legal?
It operates entirely outside the regulated market. The deals are private arrangements with no legal enforceability, no exchange, no clearing corporation and no recourse if the other side does not pay. It is not a market you have any protection in.
How accurate is GMP as a predictor of listing price?
Directionally useful, frequently wrong on magnitude, and least reliable exactly when it matters most — in the frothiest issues. It reflects sentiment on the day it is quoted, and sentiment can turn in the days between allotment and listing.
Why does GMP change so much?
The volumes behind the quote are small, so a handful of trades moves it. It also responds to subscription data, broad market moves and the anchor list, none of which changes the underlying business.
Should GMP affect whether I apply?
It should not be the reason you apply. If a high GMP is your entire thesis, you are relying on an unregulated quote to predict the behaviour of a market you have not analysed.